ES2900283T3 - Proceso mejorado para la fabricación de clorhidrato de (R)-6-hidroxi-8-[1-hidroxi-2-[2-(4-metoxifenil)-1,1-dimetiletilaminoetil]-2H-1,4-benzoxazin-3(4H)-ona - Google Patents
Proceso mejorado para la fabricación de clorhidrato de (R)-6-hidroxi-8-[1-hidroxi-2-[2-(4-metoxifenil)-1,1-dimetiletilaminoetil]-2H-1,4-benzoxazin-3(4H)-ona Download PDFInfo
- Publication number
- ES2900283T3 ES2900283T3 ES17816861T ES17816861T ES2900283T3 ES 2900283 T3 ES2900283 T3 ES 2900283T3 ES 17816861 T ES17816861 T ES 17816861T ES 17816861 T ES17816861 T ES 17816861T ES 2900283 T3 ES2900283 T3 ES 2900283T3
- Authority
- ES
- Spain
- Prior art keywords
- salt
- compound
- olodaterol
- formula
- methoxyphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/60—Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
- C07C2603/66—Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382628 | 2016-12-20 | ||
| EP17382449 | 2017-07-10 | ||
| PCT/EP2017/083444 WO2018114887A1 (en) | 2016-12-20 | 2017-12-19 | Improved process for the manufacture of r-6-hydroxy-8-[1-hydroxy-2-[2-(4-methoxyphenyl)-1,1-dimethylethylaminoethyl]-2h-1,4-benzoxazin-3(4h)-one hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2900283T3 true ES2900283T3 (es) | 2022-03-16 |
Family
ID=60702800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17816861T Active ES2900283T3 (es) | 2016-12-20 | 2017-12-19 | Proceso mejorado para la fabricación de clorhidrato de (R)-6-hidroxi-8-[1-hidroxi-2-[2-(4-metoxifenil)-1,1-dimetiletilaminoetil]-2H-1,4-benzoxazin-3(4H)-ona |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10800748B2 (enExample) |
| EP (1) | EP3558954B1 (enExample) |
| JP (1) | JP7116060B2 (enExample) |
| CN (1) | CN110114346B (enExample) |
| DK (1) | DK3558954T3 (enExample) |
| ES (1) | ES2900283T3 (enExample) |
| HR (1) | HRP20211915T1 (enExample) |
| PL (1) | PL3558954T3 (enExample) |
| WO (1) | WO2018114887A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108997248B (zh) * | 2018-08-06 | 2023-08-01 | 上海方予健康医药科技有限公司 | 盐酸奥达特罗晶型b及其制备方法 |
| CN108822054B (zh) * | 2018-08-06 | 2021-06-22 | 上海方予健康医药科技有限公司 | 盐酸奥达特罗晶型c及其制备方法 |
| CN109096218B (zh) * | 2018-08-06 | 2020-10-27 | 上海方予健康医药科技有限公司 | 盐酸奥达特罗晶型a及其制备方法 |
| CN114057590A (zh) * | 2021-11-12 | 2022-02-18 | 安徽有吉医药科技有限公司 | 一种奥达特罗关键中间体的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10253282A1 (de) | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
| DE102004024454A1 (de) | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| MX2008001976A (es) * | 2005-08-15 | 2008-03-25 | Boehringer Ingelheim Int | Procedimiento para la preparacion de betamimeticos. |
| PL2125759T3 (pl) | 2007-01-25 | 2011-12-30 | Boehringer Ingelheim Int | Sposób wytwarzania związków betamimetycznych |
| US20100249550A1 (en) | 2009-03-25 | 2010-09-30 | Neilcor Puritan Bennett LLC | Method And Apparatus For Optical Filtering Of A Broadband Emitter In A Medical Sensor |
-
2017
- 2017-12-19 JP JP2019529170A patent/JP7116060B2/ja active Active
- 2017-12-19 PL PL17816861T patent/PL3558954T3/pl unknown
- 2017-12-19 DK DK17816861.3T patent/DK3558954T3/da active
- 2017-12-19 HR HRP20211915TT patent/HRP20211915T1/hr unknown
- 2017-12-19 ES ES17816861T patent/ES2900283T3/es active Active
- 2017-12-19 US US16/465,762 patent/US10800748B2/en active Active
- 2017-12-19 EP EP17816861.3A patent/EP3558954B1/en active Active
- 2017-12-19 CN CN201780078487.7A patent/CN110114346B/zh active Active
- 2017-12-19 WO PCT/EP2017/083444 patent/WO2018114887A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US10800748B2 (en) | 2020-10-13 |
| JP2020502077A (ja) | 2020-01-23 |
| CN110114346A (zh) | 2019-08-09 |
| JP7116060B2 (ja) | 2022-08-09 |
| HRP20211915T1 (hr) | 2022-03-18 |
| US20200062723A1 (en) | 2020-02-27 |
| DK3558954T3 (da) | 2021-12-06 |
| CN110114346B (zh) | 2023-10-31 |
| EP3558954A1 (en) | 2019-10-30 |
| EP3558954B1 (en) | 2021-11-03 |
| PL3558954T3 (pl) | 2022-01-31 |
| WO2018114887A1 (en) | 2018-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2900283T3 (es) | Proceso mejorado para la fabricación de clorhidrato de (R)-6-hidroxi-8-[1-hidroxi-2-[2-(4-metoxifenil)-1,1-dimetiletilaminoetil]-2H-1,4-benzoxazin-3(4H)-ona | |
| JP2020172516A (ja) | マクロライド固体状形態 | |
| EP2768806B1 (en) | Method for preparing silodosin | |
| CN113227045B (zh) | 取代的杂环稠合的γ-咔啉的合成 | |
| JPWO1998030548A1 (ja) | 5−HT▲下2c▼受容体作用薬及びアミノアルキルインダゾール誘導体 | |
| FI110096B (fi) | Menetelmä terapeuttisesti käyttökelpoisen kiteisen Tiagabine-hydrokloridimonohydraatin valmistamiseksi | |
| JP2019523273A (ja) | ベリノスタットの多形形態、およびその調製のためのプロセス | |
| CN1578762A (zh) | 外消旋坦洛新游离碱和制备它的方法 | |
| EP2948432A1 (en) | Process for making ivabradine | |
| KR20160110517A (ko) | 인돌린 화합물의 제조 방법 | |
| JP2019108351A (ja) | モリンドン及びその塩の製造方法 | |
| ES2446365T3 (es) | Procedimiento de preparación de neramexane | |
| EP2978745B1 (en) | Process for the manufacture of (r)-5-[2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-(1h)-quinolin-2-one | |
| EP3347345B1 (en) | Mixed solvate of (r)-5-[2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-1h-quinolin-2-one l-tartrate | |
| WO2014096373A1 (en) | Process for prepararing n-(2-(7-methoxy-1-naphthalenyl)ethyl) acetamide and solid forms thereof | |
| US20120253051A1 (en) | Process for the preparation of ropinirole and salts thereof | |
| US10927121B1 (en) | Technologies for removing residual solvent from nalmefene hydrochloride and producing crystalline nalmefene hydrochloride monohydrate, monosolvate, or crystalline nalmefene hydrochloride dihydrate | |
| EA040500B1 (ru) | Улучшенный способ получения гидрохлорида r-6-гидрокси-8-[1-гидрокси-2-[2-(4-метоксифенил)-1,1-диметилэтиламиноэтил]-2h-1,4-бензоксазин-3(4h)-она | |
| WO2017108972A1 (en) | Compounds of r-(-)-(e)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1 -imidazolylacetonitrile-ha (luliconazole-ha) as antifungals | |
| EP0427605A1 (fr) | Nouveaux dérivés de la morpholine, leur procédé de préparation et les compositions pharmaceutiques les renfermant | |
| JP5156381B2 (ja) | N−メチル−N−(3−{3−[2−チエニルカルボニル]−ピラゾール−[1,5−α]−ピリミジン−7−イル}フェニル)アセトアミドの水和物ならびにそれに関連するプロセスおよび方法 | |
| EP2917189B1 (en) | Process for making linezolid | |
| HK40058208A (en) | Substituted heterocycle fused gamma-carbolines synthesis | |
| WO2018115181A1 (en) | New salt of ivabradine and uses thereof |